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From the Institute of Pathological Anatomy, University of
Copenhagen, Denmark.
Received for publication June 11, 1948.
EARLIER investigations by Weigert and Mottram (1946) have shown that 3:4-
benzpyrene after administration to the animal organism is metabolized to at
least four different derivatives, labelled by Weigert and Mottram as BPX1,
BPX2, BPF BPF. In a later investigation Weigert, Calcutt and Powell showed
that after application of 3:4-benzypyrene to the skin of mice only the presence of
BPX2 was detected.
That a similarity exists between the metabolism of 3:4-benzpyrene in animals
and human beings (patients suffering from leukaemia) has already been shown
(Iversen, 1947).
The following investigation shows that the intravenous injection of 3:4-
benzpyrene in human beings has an effect upon the amount ofnitrogeninplasma,
and that only-or mainly-the BPX1 derivatives are found in plasma.
MATERIAL AND METHODS.
One part of 3:4-benzpyrene was fused with four parts of Postonal (a poly-
merization product of ethylenoxide), and carbon-dioxide free distilled water was
added to the me]ted mixture, which was then shaken vigorously. This emulsion
was stable for 3-4 hours. The diameter of the particles of the emulsion was
between 6 to 15k.
Immediately after the emulsion was prepared it was injected intravenously
in patients suffering from myeloid or lymphatic leukaemia. The doses used
were 300, 500 and 800 mg. 3:4-benzpyrene in 30, 40 and 80 c.c. emulsion.
Blood samples (one part 3-8 per cent sodium-citrate solution plus 9 parts
blood) were taken from a cubital vein immediately before, immediately after
and at various times after the injection. The refractive index determined in
sodium light with an Abbe's refractometer and the content of nitrogen by means
of Kjeldahl analysis were determined in plasma obtained after centrifuging the
blood samples for half an hour at 2000 r.p.m.
Five c.c. ethanol was added to 2 c.c. plasma, and after centrifuging for 15
minutes at 2000 r.p.m., the alcoholic solution was poured inrto measure glasses
and the volume made up to 7 c.c. with ethanol, whereafter the absorption of the
alcoholic solution was measured on a Beckmann photo-electric spectrophoto-
meter.
After the precipitate was dried to constant weight the amount of nitrogen in
the precipitate was determined by Kjeldahl analysis.
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Fic. 1.-A and B show the amount in mg. of dried precipitate in plasma from different blood
samples obtained at various times before and after the injection. C and D show the
variation of the refractive index of plasma in relation to the injection. E and F show
the amount of nitrogen in (475 mm.3) plasma.
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Fig. 1, curves A and B, shows a distinct decrease in the weight ofprecipitate
which is most conspicuous at approximately 15 minutes after the injection.
In curves c and D also the decrease is greatest at approximately 15 minutes
after the injection.
Curves E and F show the same fluctuations as in A, B, C and D.
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FIo. 2.-Absorption curves of plasma extracted with ethanol before and after intravenous
injection of 3:4-benzpyrene.
In order to make sure that the emulsifier (Postonal) itselfhad no effect on the
amount of nitrogen in plasma, 8 g. of Postonal, which is more than twice the
amount ordinarily used for the benzpyrene emulsions, were injected intravenously
into a patient. No changes in the plasma as described above were noticed.
Fig. 2 shows that the maxima of absorption characteristic of 3:4-benzpyrene
are, little by little, altered to maxima of absorption characteristic of the meta-
bolites labelled as BPX1. The differences in position on the ordinate axis are
seen to correspond with the fluctuations in the amount of nitrogen in plasma,
which may mean that the fraction of alcohol-soluble substances varies corre-
spondingly.
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The results of Kjeldahl analysis on the precipitates showed that there was no
noticeable difference between the percentage of nitrogen in the different samples
of precipitate, which may mean that the composition of protein in plasma does
not alter considerably in relation to an intravenous injection of 3:4-benzpyrene,
or that it varies so little that it has been impossible, with the technique used, to
determine the difference.
It would be possible to obtain a quantitative estimation of the proportion
between the amount of unchanged benzpyrene and changed benzpyrene, and thus
get an expression for the speed with which the metabolism (or detoxication ?)
of 3:4-benzpyrene takes place by determining the proportions between the
extinction at 380 m,u. (maximum for X1 derivative) and at 385 m,u. (maximum
for 3:4-benzpyrene).
The quotient E 380 m[. for benzpyrene in 10 singledeterminationswas shown E 385 m[~.
to be 0.8599. The same quotient for the X1 derivative is unknown and could not
be determined, as it was not possible to obtain the X1 derivative in a pure form,
but the quotient must be higher than 1 00, as the absorption of the Xlderivative
is more intense at 380 m,. than at 385 m,.
The quotients obtained from alcohol-extracted plasma at different timesbefore
and after the injection are shown in Fig. 1, curves G and H. The curves show
that the concentration of unchanged benzpyrene rapidly decreases, whereas the
concentration of changed benzpyrene (X1 derivative) rapidly increases. The
curves further show that the time at which the rate of conversion is highest
nearly coincides with the time at which the decrease in nitrogen-(protein-) con-
tent of the plasma is most conspicuous. Additionally the curves indicate that
after the maximum concentration of changed hydrocarbon has been reached,
elimination takes place at a constant speed.
Thatthe conversion may take place in the liver after an intravenousinjection
is an obvious consideration, and the following experiment would indicate that
this is the case in rabbits:
Blood is transfused through a living rabbit liver (Nielsen, 1933), and to the
circulating blood is added 10 mg. 3:4-benzpyrene emulsified in the usual way;
samplesof blood are taken before and at various times after the injection. Fig. 3
shows, as in the case of human beings, that the absorption maxima of 3:4-
benzpyrene are altered gradually to the maxima of absorption characteristic of
the X1 derivatives. That these curves appear higher and higher on the ordinate
axis may be accounted for by the fact that it is not possible for the system to
excrete. The variations in the quotient 380/385 m,u. from two such experiments
with rabbits are seen in Fig. 4, curves D and E. The quotients for the alcohol
extracted livers were 1.10 and 1.02. The fact that these quotients are higher
than in the sera strongly supports the theory that the conversion of the hydro-
carbon takes place in the liver.
Fig. 4, curve c, shows the variations of the quotient 380/385 mir. for alcohol-
extracted plasma from a patient suffering from lymphatic leukaemia. This
curve has a noticeably different course from the quotient curve obtained from
myeloid leukaemia, which may mean a slower rate of conversion, in the case of
lymphatic leukaemia. WVhether this difference in the rate of conversion of
3:4-benzpyrene is due to differences in the individuals themselves, to differences
in the amount of benzpyrene injected, or to a difference between myeloid and
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lymphatic leukaemia, it is not yet possible to decide, since the material'on lym-
phatic leukaemia has been too limited to permit definite conclusions. Fig. 4,
curve c, indicates clearly that the conversion takes place at a markedly lower
speed than in the other instances mentioned. In this connection it is an interest-
ing phenomenon that it seems easier to influence a lymphatic leukaemia by
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FIG. 3.-Absorption curves of the alcohol-extracted rabbit sera. (Defibrinated blood was
nsed in the system.)
intravenous injections of polycyclic aromatic hydrocarbons than to influence a
myeloid leukaemia (J. Engelbreth-Holm, private communiqation).
There are some observations which indicate that the metabolism of 3:4-benz-
pyrene is accompanied by changes in the metabolism of the protein. Thus it is
a common reaction in all patients, after intravenous injection of benzpyrene (or
other carcinogenic hydrocarbons), to get an attack of high temperature (40-41°
C.), which appears approximately 1-2 hours after the injection and lasts for
4-6 hours. One of the patients, after an injection of 500 mg. benzpyrene, pre-
ceded by four earlier injections, sustained a severe attack of (protein?) shock,
which appeared 4-5 hours after the injection and lasted for 2-3 hours. It ought
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perhapstobementionedinthis connectionthatthepatientsduring, orimmediately
after, but never later than half an hour after the injection, sometimes got slight
attacks ofpulmonary infarcts.
Whether one considers the changes in the amount of nitrogen (protein) in
plasma as attached to the metabolism of3:4-benzpyrene or as bearing no relation
Mlurt$.
FIG. 4.-A and B Myeloid leukaemia. C = Lymphatic leukaemia. D and E = Rabbit.
to the conversion of 3:4-benzpyrene, but accompanying the intravenous injection
of 3:4-benzpyrene in an apparently regular way, it is possible, if one considers
the concentration ofunchanged benzpyrene as being highest in the blood sample
obtained immediately after the injection, to calculate the relative amounts of
X1 derivative of the different blood samples by using the following equation:
ak k
k ( L- L (Al_- L) - 0
1 1
a k
L0 --L ( -BL L ) -
(Al KL-
(B1
- KL)) LI 1 /
cone. X
conc. Y
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in which Lo and L1 represent the wave-lengths 380 m,t. and 385 m,..; A, A', B
and B1 the extinctions at the wave-lengths L0 and L1 for the two samples in
question; aandb the extinctions atL0andL1 forthe sample obtained immediately
after the injection; and kc and K the extinctions at the wave-lengths L0 and L,
for the sample obtained immediately before the injection.
The results are given graphically in Fig. 5.
_w
+ *03
+ 02
+-O/
- 00
-'01
- 02
-.03
- .03
- ad
-O5
I
i
! i
-U
1-
I
I
!-
I
I
//
//
_'/
Ii
-7 .-
Ifr
2
/
/ 7
I
I
I
r'/
-
e=:
/
II
I
--
ItRLAT/rV A/L/Ts OF X, eR/VATi/.
d
o
\.\
,1¢
[C
|j
f,I
1,7
47
t,5
;.4
1,s
;.2
f I
U 75 .W 45 40 S Of Of 1N 135- 150US5 SO O9 ?0 1 50 Nt 240 ?
O 5is ff to 75 90 NS031 4 V?S /s r DJ rn? 552t70 / / /Us£-$
FIG. 5.-A and B show the variations in the quotient 380/385 mj. (left ordinate axis). C and
D give the corresponding relative amounts of X2 derivative calculated in the way described
(right ordinate axis).
From Fig. 5, curves c and D, and Table I, it is seen that both the conversion
of 3:4-benzpyrene to the X1 derivative and the elimination ofthe X1 derivative
from plasma (= conversion of X1 to X2 derivative?) follow the equation for the
rate of a monomolecular reaction.
SUMMARY.
In relation to an intravenous injection of 3:4-benzpyrene a decrease in the
amount of nitrogen (protein) in plasma is observed. The decrease is of rather
short duration, and is most conspicuous at the time when the conversion of 3:4-
benzpyrene is most intense.
After intravenous injection of 3:4-benzpyrene in human beings only the
absorption characteristic of the BPX1 derivatives are observed.
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TABLE I.
1 a K x log a
t a--x'
t. log
a K.
a-x
Fig. 5, curve D'
15 . 00434 . 0002893
30 . 00945 . 0003150
45 . 0 1496 . 0'003320
60 . 02082 . 0'003470
75 . 0*2764 . 0003685
15 . 00069 . 0000460
30 . 0*0141 . 0000470
75 . 0*0366 . 0000488
Fig. 5, curve C:
30 . 00607 . 0.002023
45 . 0*0899 . 0*001998
60 . 01303 . 0'002171
75 . 01553 . 0002071
90 . 01790 . 0'001989
105 . 02122 . 0002021
120 . 02405 . 0002004
30 . 0'0390 . 000130
45 . 0*0941 . 0'00125
90 . 01614 . 0*00135
Experiments with rabbits indicate the probability that the conversion of
3:4-benzpyrene after intravenous injection takes place in the liver.
A method is given of estimating the process of conversion. Relative esti-
mations ofthe amounts ofX1 derivative in plasma show that both the conversion
of 3:4-benzpyrene to the X1 derivative and the elimination ofX1 derivative from
plasma follow the equation for the rate of a monomolecular reaction.
These investigations have been supported by grants from the Anders lHassel-
balch Leukaemia-Fond, the Kong Christian den Tiendes Fond and Landsforen-
ingen til Kraeftens Bekaempelse.
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